A predictive algorithm estimating individual risk of kidney allograft loss up to 10 years post-transplant, used as a surrogate endpoint in clinical trials and patient care.

A platform feature that creates synthetic control arms for clinical trials by generating matched historical control cohorts to reduce trial costs and timelines.